Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Boehringer Ingelheim
Harvard Business School
Johnson and Johnson
McKinsey

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Litigation Details for Forest Laboratories Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2014)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Forest Laboratories Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2014)

Docket   Start Trial Date Filed 2014-04-21
Court District Court, D. Delaware Date Terminated 2015-11-20
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand Defendant Referred To
Parties ADAMAS PHARMACEUTICALS INC.; AMERIGEN PHARMACEUTICALS INC.; AMERIGEN PHARMACEUTICALS LTD.; AMNEAL PHARMACEUTICALS LLC; AMNEAL PHARMACEUTICALS OF NEW YORK LLC; AMNEAL PHARMACEUTICALS OF NEW YORK, LLC; FOREST LABORATORIES HOLDINGS LTD.; FOREST LABORATORIES INC.; MERZ PHARMA GMBH & CO. KGAA; MERZ PHARMACEUTICALS GMBH; MYLAN PHARMACEUTICALS INC.
Patents 5,061,703; 8,058,291; 8,168,209; 8,173,708; 8,283,379; 8,329,752; 8,362,085; 8,598,233
Attorneys Anandita Vyakarnam; Anne Shea Gaza; Constance S. Huttner; David A. Bilson; Eric R. Hunt; Jack B. Blumenfeld; James C. Grant; James P. Barabas; John C. Phillips , Jr.; Jonathan D. Parente; Kelly E. Farnan; Lance A Soderstrom; Maryellen Noreika; Neal C. Belgam; Paul J. Molino; Samantha G. Wilson; Tara M. Raghaven; William A. Rakoczy
Firms Phillips, Goldman, McLaughlin & Hall, P.A.
Link to Docket External link to docket
Small Molecule Drugs cited in Forest Laboratories Inc. v. Mylan Pharmaceuticals Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for Forest Laboratories Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-04-21 6 l'/,rnn OR fRAm~IAHJ'; I 5,061.703 10129/1 99… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See attached;.… OF PATENT HOLDEK OF PATENT nJ~… 20 November 2015 1:14-cv-00508 830 Patent Defendant District Court, D. External link to document
2014-09-08 65 Paragraph 16: Plaintiffs admit that U.S. Patent No. 8,058,291 states on its face that it issued on November…708 patent, the '379 patent, the '752 patent, the '085 patent, and the '233 patent are…;209 patent, the '708 patent, the '379 patent, the '752 patent, the '085 patent, and …;009 patent, the '209 patent, the '708 patent, the '379 patent, the '752 patent, the …;009 patent, the '209 patent, the '708 patent, the '379 patent, the '752 patent, the External link to document
2015-01-15 99 Initial Invalidity Contentions for U.S. Patent No. 5,061,703, accompanying exhibit(s) and FTP site instructions… 20 November 2015 1:14-cv-00508 830 Patent Defendant District Court, D. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Merck
McKinsey
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.